Literature DB >> 22425411

A stage I pilot study of acceptance and commitment therapy for methadone detoxification.

Angela L Stotts1, Charles Green, Akihiko Masuda, John Grabowski, Kelly Wilson, Thomas F Northrup, F Gerard Moeller, Joy M Schmitz.   

Abstract

BACKGROUND: While agonist replacement therapies are effective for managing opioid dependence, community treatment programs are increasingly choosing detoxification. Unfortunately, success rates for opioid detoxification are very low, in part, due to physical and psychological symptoms associated with opioid withdrawal. Few behavior therapies specifically address the distressing experiences specific to opioid withdrawal. A novel behavioral treatment, acceptance and commitment therapy (ACT), works from the premise that the avoidance of unpleasant private experiences (thoughts, feelings, bodily sensations) is ubiquitous yet may be pathogenic, resulting in treatment drop-out and further drug use.
METHODS: This Stage I pilot study developed and tested an ACT-based opioid detoxification behavioral therapy. Opioid dependent patients (N=56) who were attending a licensed methadone clinic were randomized to receive either 24 individual therapy sessions of ACT or drug counseling (DC) in the context of a 6-month methadone dose reduction program.
RESULTS: While no difference was found on opioid use during treatment, 37% of participants in the ACT condition were successfully detoxified at the end of treatment compared to 19% of those who received DC. Fear of detoxification was also reduced across time in the ACT condition relative to DC.
CONCLUSION: This first study of ACT to assist opioid detoxification indicates promise. Research is needed to refine specific treatment strategies for this population to further strengthen effects.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425411      PMCID: PMC3386351          DOI: 10.1016/j.drugalcdep.2012.02.015

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  34 in total

1.  One-, three-, and six-month outcomes after brief inpatient opioid detoxification.

Authors:  M A Chutuape; D R Jasinski; M I Fingerhood; M L Stitzer
Journal:  Am J Drug Alcohol Abuse       Date:  2001-02       Impact factor: 3.829

2.  Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study.

Authors:  M Gossop; J Marsden; D Stewart; S Treacy
Journal:  Drug Alcohol Depend       Date:  2001-05-01       Impact factor: 4.492

3.  Slow and steady wins the race: a randomized clinical trial of acceptance and commitment therapy targeting shame in substance use disorders.

Authors:  Jason B Luoma; Barbara S Kohlenberg; Steven C Hayes; Lindsay Fletcher
Journal:  J Consult Clin Psychol       Date:  2011-10-31

4.  Methadone dose decreases and anxiety reduction.

Authors:  S M Hall; P C Loeb; M Kushner
Journal:  Addict Behav       Date:  1984       Impact factor: 3.913

Review 5.  Opioid dependence treatment: options in pharmacotherapy.

Authors:  Angela L Stotts; Carrie L Dodrill; Thomas R Kosten
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

6.  Iatrogenic phobic disorders in methadone maintenance treated patients.

Authors:  J B Milby; C Garrett; R Meredith
Journal:  Int J Addict       Date:  1980-07

7.  Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach.

Authors:  C E Green; F G Moeller; J M Schmitz; J F Lucke; S D Lane; A C Swann; R E Lasky; J P Carbonari
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

8.  Methadone maintenance outcome as a function of detoxification phobia.

Authors:  J B Milby; A A Hohmann; M Gentile; N Huggins; M K Sims; A T McLellan; G Woody; N Haas
Journal:  Am J Psychiatry       Date:  1994-07       Impact factor: 18.112

9.  Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial.

Authors:  Paolo Mannelli; Ashwin A Patkar; Kathi Peindl; David A Gorelick; Li-Tzy Wu; Edward Gottheil
Journal:  Addict Biol       Date:  2008-08-19       Impact factor: 4.280

10.  A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.

Authors:  Valerie A Gruber; Kevin L Delucchi; Anousheh Kielstein; Steven L Batki
Journal:  Drug Alcohol Depend       Date:  2008-04-01       Impact factor: 4.492

View more
  15 in total

1.  Analgesic reduction during an interdisciplinary pain management programme: treatment effects and processes of change.

Authors:  Beth J Guildford; Aisling Daly-Eichenhardt; Bethany Hill; Karen Sanderson; Lance M McCracken
Journal:  Br J Pain       Date:  2017-10-02

2.  The psychology of chronic post-surgical pain: new frontiers in risk factor identification, prevention and management.

Authors:  Aliza Z Weinrib; Muhammad A Azam; Kathryn A Birnie; Lindsay C Burns; Hance Clarke; Joel Katz
Journal:  Br J Pain       Date:  2017-07-12

3.  A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual.

Authors:  Joy M Schmitz; Angela L Stotts; Anka A Vujanovic; Michael F Weaver; Jin H Yoon; Jessica Vincent; Charles E Green
Journal:  Contemp Clin Trials       Date:  2017-12-26       Impact factor: 2.226

4.  The Promise of Third-Wave Behavioral Therapies in the Treatment of Substance Use Disorders.

Authors:  Angela L Stotts; Thomas F Northrup
Journal:  Curr Opin Psychol       Date:  2015-04-01

5.  Psychological Flexibility and Depression in New Mothers of Medically Vulnerable Infants: A Mediational Analysis.

Authors:  Angela L Stotts; Yolanda R Villarreal; Michelle R Klawans; Robert Suchting; Lillian Dindo; Allison Dempsey; Mackenzie Spellman; Charles Green; Thomas F Northrup
Journal:  Matern Child Health J       Date:  2019-06

Review 6.  Delay discounting and the use of mindful attention versus distraction in the treatment of drug addiction: a conceptual review.

Authors:  Melinda L Ashe; Michelle G Newman; Stephen J Wilson
Journal:  J Exp Anal Behav       Date:  2014-12-25       Impact factor: 2.468

Review 7.  A contextual model of self-regulation change mechanisms among individuals with addictive disorders.

Authors:  Corey R Roos; Katie Witkiewitz
Journal:  Clin Psychol Rev       Date:  2017-08-24

Review 8.  Methadone at tapered doses for the management of opioid withdrawal.

Authors:  Laura Amato; Marina Davoli; Silvia Minozzi; Eliana Ferroni; Robert Ali; Marica Ferri
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

9.  Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model.

Authors:  Thomas F Northrup; Angela L Stotts; Charles Green; Jennifer S Potter; Elise N Marino; Robrina Walker; Roger D Weiss; Madhukar Trivedi
Journal:  Addict Behav       Date:  2014-09-28       Impact factor: 3.913

10.  A pilot study of a distress tolerance treatment for opiate-dependent patients initiating buprenorphine: rationale, methodology, and outcomes.

Authors:  Richard A Brown; Erika Litvin Bloom; Jacki Hecht; Ethan Moitra; Debra S Herman; Michael D Stein
Journal:  Behav Modif       Date:  2014-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.